Preloader
Global Predictive Disease Analytics Market Size, Trends & Growth Opportunity, By Component (Software & Services, Hardware), By Deployment (On-premise, Cloud-based), By End-use (Healthcare Payers, Healthcare Providers, Other) By Region and Forecast till 2030.


Report ID : IR1002248 | Industries : Healthcare | Published On :June 2024 | Page Count : 254

  • Request Sample      Ask for Customization     Inquire Before Buying     Speak to Analyst



  • Global Predictive Disease Analytics Market Size, Trends & Growth Opportunity, By Component (Software & Services, Hardware), By Deployment (On-premise, Cloud-based), By End-use (Healthcare Payers, Healthcare Providers, Other) By Region and Forecast till 2030.
    Global Predictive Disease Analytics Market
    The global Predictive Disease Analytics market was valued at USD 2.8 billion in 2022 which expected to reach USD 10.2 billion by 2030 at a CAGR 17.02 % from 2023-2030.
    Predictive analytics is a subset of advanced analytics that uses modelling, data mining, statistics, and artificial intelligence to make predictions and improve decision-making (AI). Big data and predictive analytics aid in the improvement of healthcare organization operational management, the accuracy of diagnosis and treatment in personal medicine, and increased insights to improve cohort treatment.
    Market Drivers
    The rise in government initiatives, as well as increased investment in the healthcare industry, are two key reasons for the increased adoption of predictive analytical tools in the healthcare sector. For example, in February 2023, the European Commission invested USD 7.2 million in a new project aimed at developing an AI-based platform for collecting and analyzing clinical data on new oncology medicines in order to support their evaluation by regulators and health technology assessment (HTA) agencies. 
    Market challenges
    The healthcare industry has faced challenges such as rising treatment costs, a lack of better patient care, and decreased patient retention and engagement. As a result, predictive disease analytics are being used across the industry to provide better patient care and improve operations. These are the primary drivers of the healthcare analytics industry's expansion. For example, Hartford HealthCare and Google Cloud announced a long-term partnership in November 2022 to improve their healthcare system's digital transformation in order to improve data analytics and patient care.
    Impact of COVID-19 
    These bioprocessing devices, which come in sizes ranging from a few millilitres to 5-10 L, are often utilised for small-scale Componention. Due to the unexpected spike in COVID-19 cases, the COVID-19 pandemic has seen an increase in demand. Due to various companies increasing their facilities to conduct research and development for COVID-19 vaccines, small-scale bioreactor sales dramatically rose in 2020 and 2021. Additionally, it is anticipated that during the forecast period, Component sales will expand as a result of global immunisation efforts and increased demand. 
    Market Segmentation
    The Global Predictive Disease Analytics Market is segmented into Component, Deployment, Distribution Channel and Growing System. By Component such as Software & Services, Hardware. By Deployment such as On-premise, Cloud-based. By End-use such as Healthcare Payers, Healthcare Providers, Other. 
    Regional Analysis
    Global Predictive Disease Analytics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the Predictive Disease Analytics market in North America is expected to grow at the fastest CAGR. The region has the most advanced healthcare facilities, which increases platform adoption. The growing burden of chronic diseases, as well as the growing proportion of the geriatric population, have increased the demand for hospitals and other organisations to adopt analytics tools. The presence of major market participants has also contributed to the large share of revenue. Microsoft, based in the United States, will launch Microsoft Cloud for Healthcare in September 2020, which will be a collaboration between providers and patients that will aid in the delivery of better patient care insights.
    Key Players
    Various key players are listed in this report such as Oracle, IBM, SAS, Allscripts Healthcare Solutions Inc., MedeAnalytics, Inc., Health Catalyst, Apixio Inc.
    Market Taxonomy
    By Component

    • Software & Services
    • Hardware
    By Deployment
    • On-premise
    • Cloud-based
    By End-use
    • Healthcare Payers
    • Healthcare Providers
    • Other
    By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa
    Key Questions Addressed by the Report
    • What are the Key Opportunities in Global Predictive Disease Analytics Market?
    • What will be the growth rate from 2023 to 2030?
    • Which segment/region will have highest growth?
    • What are the factors that will impact/drive the Market?
    • What is the competitive Landscape in the Industry?
    • What is the role of key players in the value chain?

    Global Predictive Disease Analytics Market 
    1 Introduction 
    1.1 Objective of the Study
    1.2 Market definition
    1.3 Market Scope
    2 Research Methodology
    2.1 Data Mining
    2.2 Validation
    2.3 Primary Interviews
    2.4 List of Data Sources
    3 Executive Summary
    4 Global Predictive Disease Analytics Market Outlook
    4.1 Overview
    4.2 Market Dynamics
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.2.4 Cumulative Impact due to recent Energy Crisis
    4.2.5 Cumulative Impact due to nearing economic downturn 
    4.2.6 Post covid-19 world Supply& Demand conditions
    4.2.7 Cumulative Impact of Russia-Ukraine Conflict
    4.3 Porters Five Force Model
    4.4 Value Chain Analysis
    5 Global Predictive Disease Analytics Market, By Component
    5.1 Y-o-Y Growth Comparison, By Component 
    5.2 Global Predictive Disease Analytics Market Share Analysis, By Component 
    5.3 Global Predictive Disease Analytics Market Size and Forecast, By Component
    5.3.1 Software & Services
    5.3.2 Hardware 
    6 Global Predictive Disease Analytics Market, By Deployment
    6.1 Y-o-Y Growth Comparison, By Deployment
    6.2 Global Predictive Disease Analytics Market Share Analysis, By Deployment
    6.3 Global Predictive Disease Analytics Market Size and Forecast, By Deployment
    6.3.1 On-premise
    6.3.2 Cloud-based
    7 Global Predictive Disease Analytics Market, By End-use
    7.1 Y-o-Y Growth Comparison, By End-use
    7.2 Global Predictive Disease Analytics Market Share Analysis, By End-use
    7.3 Global Predictive Disease Analytics Market Size and Forecast, By End-use
    7.3.1 Healthcare Payers
    7.3.2 Healthcare Providers
    7.3.3 Others 
    8 Global Predictive Disease Analytics Market, By Region
    8.1 Global Predictive Disease Analytics Market Share Analysis, By Region
    8.2 Global Predictive Disease Analytics Market Share Analysis, By Region
    8.3 Global Predictive Disease Analytics Market Size and Forecast, By Region
    9 North America Predictive Disease Analytics Market Analysis and Forecast (2023-2030)
    9.1 Introduction
    9.2 North America Predictive Disease Analytics Market Share Analysis, By Component
    9.3 North America Predictive Disease Analytics Market Size and Forecast, By Deployment
    9.4 North America Predictive Disease Analytics Market Size and Forecast, By End-use
    9.6 North America Predictive Disease Analytics Market Size and Forecast, By Country
    9.7.1 U.S.
    9.7.2 Canada
    9.7.3 Mexico
    10 Europe Predictive Disease Analytics Market Analysis and Forecast (2023-2030)
    10.1 Introduction
    10.2 Europe Predictive Disease Analytics Market Share Analysis, By Component 
    10.3 Europe Predictive Disease Analytics Market Size and Forecast, By Deployment 
    10.4 Europe Predictive Disease Analytics Market Size and Forecast, By End-use
    10.6 Europe Predictive Disease Analytics Market Size and Forecast, By Country
    10.6.1 Germany
    10.6.2 France
    10.6.3 UK
    10.6.4. Rest of Europe
    11 Asia Pacific Predictive Disease Analytics Market Analysis and Forecast (2023-2030)
    11.1 Introduction
    11.2 Asia Pacific Predictive Disease Analytics Market Share Analysis, By Component 
    11.3 Asia Pacific Predictive Disease Analytics Market Size and Forecast, By Deployment 
    11.4 Asia Pacific Predictive Disease Analytics Market Size and Forecast, By End-use
    11.6 Asia Pacific Predictive Disease Analytics Market Size and Forecast, By Country
    11.6.1 China 
    11.7.2 Japan
    11.8.3 India
    11.8.4. Rest of Asia Pacific
    12 Latin America Predictive Disease Analytics Market Analysis and Forecast (2023-2030)
    12.1 Introduction
    12.2 Latin America Predictive Disease Analytics Market Share Analysis, By Component 
    12.3 Latin America Predictive Disease Analytics Market Size and Forecast, By Deployment 
    12.4 Latin America Predictive Disease Analytics Market Size and Forecast, By End-use
    12.6 Latin America Predictive Disease Analytics Market Size and Forecast, Country
    12.7.1. Brazil
    12.8.2. Rest of Latin America
    13 Middle East Predictive Disease Analytics Market Analysis and Forecast (2023-2030)
    13.1 Introduction
    13.2 Middle East Predictive Disease Analytics Market Share Analysis, By Component 
    13.3 Middle East Predictive Disease Analytics Market Size and Forecast, By Deployment 
    13.4 Middle East Predictive Disease Analytics Market Size and Forecast, By End-use
    13.6 Middle East Predictive Disease Analytics Market Size and Forecast, By Country
    13.7.1. Saudi Arabia
    13.8.2. UAE
    13.8.3. Egypt
    13.9.4. Kuwait
    13.10.5. South Africa
    14 Competitive Analysis
    14.1 Competition Dashboard
    14.2 Market share Analysis of Top Vendors
    14.3 Key Development Strategies
    15 Company Profiles
    15.1 Oracle
    15.1.1 Overview
    15.1.2 Components
    15.1.3 Key Financials
    15.1.4 Business Segment & Geographic Overview
    15.1.5 Key Market Developments
    15.1.6 Key Strategies
    15.2. IBM
    15.2.1 Overview
    15.2.2 Components
    15.2.3 Key Financials
    15.2.4 Business Segment & Geographic Overview
    15.2.5 Key Market Developments
    15.2.6 Key Strategies
    15.3. SAS
    15.3.1 Overview
    15.3.2 Components
    15.3.3 Key Financials
    15.3.4 Business Segment & Geographic Overview
    15.3.5 Key Market Developments
    15.3.6 Key Strategies
    15.4 Allscripts Healthcare Solutions Inc.
    15.4.1 Overview
    15.4.2 Components
    15.4.3 Key Financials
    15.4.4 Business Segment & Geographic Overview
    15.4.5 Key Market Developments
    15.4.6 Key Strategies
    15.5 MedeAnalytics, Inc.
    15.5.1 Overview
    15.5.2 Components
    15.5.3 Key Financials
    15.5.4 Business Segment & Geographic Overview
    15.5.5 Key Market Developments
    15.5.6 Key Strategies
    15.6 Health Catalyst
    15.6.1 Overview
    15.6.2 Components
    15.6.3 Key Financials
    15.6.4 Business Segment & Geographic Overview
    15.6.5 Key Market Developments
    15.6.6 Key Strategies
    15.7 Apixio Inc.
    15.7.1 Overview
    15.7.2 Components
    15.7.3 Key Financials
    15.7.4 Business Segment & Geographic Overview
    15.7.5 Key Market Developments
    15.7.6 Key Strategies